Similar articles for PMID: 36657982

Year	Number of Results
2004	1
2005	1
2010	1
2013	1
2014	1
2015	9
2016	18
2017	18
2018	24
2019	34
2020	27
2021	29
2022	24
2023	10
2024	0

1

Consecutive Prostate-Specific Membrane Antigen (PSMA) and Antigen Receptor (AR) PET Imaging Shows Positive Correlation with AR and PSMA Protein Expression in Primary Hormone-Naïve Prostate Cancer.

Al Jalali V, Wasinger G, Rasul S, Grubmüller B, Wulkersdorfer B, Balber T, Mitterhauser M, Simon J, Hacker M, Shariat S, Egger G, Zeitlinger M. Al Jalali V, et al. J Nucl Med. 2023 Jun;64(6):863-868. doi: 10.2967/jnumed.122.264981. Epub 2023 Jan 19. J Nucl Med. 2023. PMID: 36657982

2

Cold Kit for Prostate-Specific Membrane Antigen (PSMA) PET Imaging: Phase 1 Study of ⁶⁸Ga-Tris(Hydroxypyridinone)-PSMA PET/CT in Patients with Prostate Cancer.

Hofman MS, Eu P, Jackson P, Hong E, Binns D, Iravani A, Murphy D, Mitchell C, Siva S, Hicks RJ, Young JD, Blower PJ, Mullen GE. Hofman MS, et al. J Nucl Med. 2018 Apr;59(4):625-631. doi: 10.2967/jnumed.117.199554. Epub 2017 Oct 6. J Nucl Med. 2018. PMID: 28986512 Free PMC article. Clinical Trial.

3

⁶⁸Ga-Labeled Prostate-specific Membrane Antigen Ligand Positron Emission Tomography/Computed Tomography for Prostate Cancer: A Systematic Review and Meta-analysis.

von Eyben FE, Picchio M, von Eyben R, Rhee H, Bauman G. von Eyben FE, et al. Eur Urol Focus. 2018 Sep;4(5):686-693. doi: 10.1016/j.euf.2016.11.002. Epub 2016 Nov 15. Eur Urol Focus. 2018. PMID: 28753806 Free article.

4

[⁶⁸Ga]PSMA-HBED-CC Uptake in Osteolytic, Osteoblastic, and Bone Marrow Metastases of Prostate Cancer Patients.

Janssen JC, Woythal N, Meißner S, Prasad V, Brenner W, Diederichs G, Hamm B, Makowski MR. Janssen JC, et al. Mol Imaging Biol. 2017 Dec;19(6):933-943. doi: 10.1007/s11307-017-1101-y. Mol Imaging Biol. 2017. PMID: 28707038

5

68Ga-PSMA-HBED-CC PET/CT imaging in Black versus White South African patients with prostate carcinoma presenting with a low volume, androgen-dependent biochemical recurrence: a prospective study.

Lengana T, van de Wiele C, Lawal I, Maes A, Ebenhan T, Boshomane T, Zeevaart JR, Ankrah A, Mokgoro N, Vorster M, Sathekge M. Lengana T, et al. Nucl Med Commun. 2018 Feb;39(2):179-185. doi: 10.1097/MNM.0000000000000791. Nucl Med Commun. 2018. PMID: 29257006 Clinical Trial.

6

A Multicenter Prospective Clinical Trial of ⁶⁸Gallium PSMA HBED-CC PET-CT Restaging in Biochemically Relapsed Prostate Carcinoma: Oligometastatic Rate and Distribution Compared With Standard Imaging.

McCarthy M, Francis R, Tang C, Watts J, Campbell A. McCarthy M, et al. Int J Radiat Oncol Biol Phys. 2019 Jul 15;104(4):801-808. doi: 10.1016/j.ijrobp.2019.03.014. Epub 2019 Mar 16. Int J Radiat Oncol Biol Phys. 2019. PMID: 30890448 Clinical Trial.

7

Prostate-specific membrane antigen-radioguided surgery for metastatic lymph nodes in prostate cancer.

Maurer T, Weirich G, Schottelius M, Weineisen M, Frisch B, Okur A, Kübler H, Thalgott M, Navab N, Schwaiger M, Wester HJ, Gschwend JE, Eiber M. Maurer T, et al. Eur Urol. 2015 Sep;68(3):530-4. doi: 10.1016/j.eururo.2015.04.034. Epub 2015 May 6. Eur Urol. 2015. PMID: 25957851

8

Comparison of ⁶⁸Ga-PSMA-617 PET/CT and ⁶⁸Ga-RM2 PET/CT in Patients with Localized Prostate Cancer Who Are Candidates for Radical Prostatectomy: A Prospective, Single-Arm, Single-Center, Phase II Study.

Schollhammer R, Robert G, Asselineau J, Yacoub M, Vimont D, Balamoutoff N, Bladou F, Bénard A, Hindié E, Gallerande HC, Morgat C. Schollhammer R, et al. J Nucl Med. 2023 Mar;64(3):379-385. doi: 10.2967/jnumed.122.263889. Epub 2022 Sep 2. J Nucl Med. 2023. PMID: 36215569 Free PMC article. Clinical Trial.

9

Combined Early and Late [⁶⁸Ga]PSMA-HBED-CC PET Scans Improve Lesion Detectability in Biochemical Recurrence of Prostate Cancer with Low PSA Levels.

Hohberg M, Kobe C, Täger P, Hammes J, Schmidt M, Dietlein F, Wild M, Heidenreich A, Drzezga A, Dietlein M. Hohberg M, et al. Mol Imaging Biol. 2019 Jun;21(3):558-566. doi: 10.1007/s11307-018-1263-2. Mol Imaging Biol. 2019. PMID: 30105521

10

Value of 68Ga-PSMA HBED-CC PET for the Assessment of Lymph Node Metastases in Prostate Cancer Patients with Biochemical Recurrence: Comparison with Histopathology After Salvage Lymphadenectomy.

Rauscher I, Maurer T, Beer AJ, Graner FP, Haller B, Weirich G, Doherty A, Gschwend JE, Schwaiger M, Eiber M. Rauscher I, et al. J Nucl Med. 2016 Nov;57(11):1713-1719. doi: 10.2967/jnumed.116.173492. Epub 2016 Jun 3. J Nucl Med. 2016. PMID: 27261524 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

147 results

Results by year